The global skin boosters market will grow from USD 1.36 billion in 2024 to USD 2.82 billion by 2030. It will register a robust CAGR of 13% between 2025 and 2030. Consumers increasingly choose skin boosters—micro-injections of hyaluronic acid, vitamins, and minerals—for hydrating, rejuvenating, and enhancing skin radiance non-invasively.
Regional and segment highlights
North America dominated the global market with a 29.5 per cent share in 2024, with the U.S. accounting for 72.8 per cent of regional revenue. However, Asia Pacific is set to grow at the fastest pace, fuelled by rising medical tourism, increasing awareness, and cost-effective treatment availability. In South Korea alone, skin boosters held a 27.9 per cent share, reflecting strong cultural acceptance of cosmetic procedures.
Mesotherapy captured 54.6% of the market share and will grow fastest, driven by customisable treatment options and minimal recovery time. Hyaluronic acid-based boosters generated 54.9% of revenues, driven by hydration benefits and FDA-approved innovations like Allergan Aesthetics’ SKINVIVE. Medical spas emerged as the leading end-use segment, leveraging customer-friendly models such as subscription discounts and loyalty programmes.
Market drivers and dynamics
Changing beauty standards, affordable non-surgical procedures, regulatory approvals, and aging population demand actively drive growth in the skin boosters market. In addition, changing beauty standards, affordable non-surgical procedures, regulatory approvals, and aging population demand actively drive growth in the skin boosters market.
The pandemic temporarily disrupted the sector, with Merz Pharma reporting a 10.3% revenue decline in 2020. However, recovery has been swift, aided by insurance offerings such as Hamilton Fraser in the UK and financing partnerships like AbbVie’s agreement with PatientFi in 2022, which have expanded access to aesthetic treatments.
Industry outlook
The global skin boosters market is characterised by technological innovation, regulatory scrutiny, and increasing M&A activity. For instance, ExoCoBio’s 2023 acquisition of BENEV Company aims to accelerate the commercialisation of exosome-based aesthetics. While alternatives such as chemical peels and laser treatments exist, skin boosters continue to hold strong appeal due to their effectiveness and minimal recovery time.
Rising consumer demand, technological advancements, and supportive financing models will drive strong growth in the skin boosters market. As a result, Asia Pacific and Europe will sustain this momentum through the decade’s end.